* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
IJGC Podcast
The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer. Join Editor-in-Chief Dr. Pedro Ramirez and his guests for an interactive and educational experience. Subscribe now or listen on your favourite podcast platform. IJGC - ijgc.bmj.com - is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.
Episodes
Tuesday Feb 08, 2022
Tuesday Feb 08, 2022
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. David M. Gershenson to discuss legends in gynecologic oncology. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research or rare ovarian cancers.
Highlights:
Mentoring is an essential component of a successful career in gynecologic oncology, and every trainee should seek a mentor early in their fellowship.
Strive to achieve the optimal work/life balance to avoid burnout over the course of your career.
The subspecialty of gynecologic oncology has been consistently gratifying for me during the past 40+ years. It provides young trainees with a myriad of wonderful opportunities and career choices.
I strongly recommend having a 5-year plan to optimize success in your professional career.
Friday Feb 04, 2022
Friday Feb 04, 2022
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Enrique Chacón and Luis Chiva to discuss the possible protective role of conization.
Thursday Feb 03, 2022
Thursday Feb 03, 2022
In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.
Monday Jan 31, 2022
Monday Jan 31, 2022
In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.
Thursday Jan 27, 2022
Thursday Jan 27, 2022
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss the article European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma. Dr. Concin is a gynaecological oncologist, ESGO president, Co-Chair of ENGOT Early Drug Development Network, and Professor at Medical University of Innsbruck, Innsbruck Austria & Kliniken Essen-Mitte, Essen, Germany.
Related Link: https://ijgc.bmj.com/content/31/12/1508
Friday Jan 21, 2022
Friday Jan 21, 2022
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Prof. Philipp Harter to discuss The DESKTOP III Trial. Prof. Harter is the director of the Department of Gynecology & Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany, and the chair of the AGO Study Group.
Highlights:
-Role of surgery for relapsed ovarian cancer is under debate
-DESKTOP III has shown a significant benefit regarding PFS and OS by secondary cytoreduction
-The data, interpretation and clinical consequences are discussed".
Friday Jan 14, 2022
Friday Jan 14, 2022
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Gloria Salvo and Dr. Rene Pareja to discuss IRTA: Open vs MIS Radical Trachelectomy. Dr. Salvo was trained as a gynecologist in Hospital Italiano de Buenos Aires, Argentina and works as a Clinical Reviewer/Data Abstractor of the Neuroendocrine Cervical Tumor Registry (NeCTuR) at MD Anderson Cancer Center. She has published several articles in cervical cancer including sentinel lymph node mapping and fertility-sparing surgery, neuroendocrine cervical carcinomas, and is the first author of the IRTA Study.
Highlights
-In this multicenter retrospective study, we found no difference in the 4.5-year DFS rates between open radical trachelectomy and minimally invasive radical trachelectomy in patients with tumors up to 2 cm, even after adjusting for potential confounding variables because of unbalanced groups.
-There was no difference in the OS rates or recurrence rates between the open surgery and MIS groups.
-Risk factors for relapse were more common in the open surgery group, but oncologic outcomes were similar for the open and minimally invasive approaches.
Thursday Jan 13, 2022
Thursday Jan 13, 2022
In this episode of the IJGC Podcast, Editorial Fellow Felix Boria discusses the contents of the January issue of IJGC in Spanish.
Thursday Jan 13, 2022
Thursday Jan 13, 2022
In this episode of the IJGC Podcast, Editorial Fellows Dimitrios Nasioudis and Floriane Jochum discuss the contents of the January issue of IJGC in English.
Friday Jan 07, 2022
Friday Jan 07, 2022
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Gabriela Benjamin to discuss a patient’s perspective on ovarian cancer. Gabriela Gesteira Benjamin 38 years old and was born in Brazil and grew up in Miami. She attended Columbia University where she studied engineering. She has worked in finance for the past 15 years and is currently a portfolio manager at Blackrock. She is the daughter of Roberto Benjamin and late Fatima Gesteira and sister to Joana Benjamin and Dr. Carolina Benjamin and proud aunt of Nico and Enzo. Gabi has a zest for life, practicing tennis, yoga, pilates, meditation, Freediving and kitesurfing just to name a few. She was diagnosed with advance stage ovarian cancer one year ago, underwent chemotherapy and hysterectomy. She is currently in remission but remains on maintenance medication.
Interviewee Info: Gabriela Benjamin (@galebaweBenjam)
Highlights:
- It benefits patients when doctors put themselves in the patient’s shoes and acknowledge how painful and difficult a cancer diagnosis is
- Treatment is not an easy journey, but staying positive and continuing to live life help in the process and often the outcome.
- You must learn to see the collateral beauty or the silver linings, whether it is the love you receive, nature or a breath you take when you feel good. This diagnosis will give you new lenses to view life with
- The choice of what center you do care in and with what Doctor makes the difference. Do your research, It is a personal choice but a very important one. For me it was a combination of experience and affinity, and I could not be happier with my choice of Dr. Ramirez and MdAnderson.